668 related articles for article (PubMed ID: 19660717)
21. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
Woo SY; Cho SH; Lee SM; Koh MB; Noh CH; Kim CW; Choi JY; Yang JM; Han JY; Lee YS
Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
[TBL] [Abstract][Full Text] [Related]
22. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature.
Kempinska A; Kwak EJ; Angel JB
Clin Infect Dis; 2005 Nov; 41(9):1277-82. PubMed ID: 16206102
[TBL] [Abstract][Full Text] [Related]
23. HBV-related events after allogeneic hematopoetic stem cell transplantatıon in a center from Turkey.
Çakar MK; Suyani E; Sucak GT; Altindal Ş; Aki SZ; Acar K; Yağci M; Rota S; Özenirler S
Ann Hematol; 2013 Mar; 92(3):395-402. PubMed ID: 23143119
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
[TBL] [Abstract][Full Text] [Related]
25. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B virus reactivation is a risk factor for development of post-transplant lymphoproliferative disease after liver transplantation.
Zhang A; Zhang M; Shen Y; Wang W; Zheng S
Clin Transplant; 2009; 23(5):756-60. PubMed ID: 19664018
[TBL] [Abstract][Full Text] [Related]
27. Permanent loss of anti-HBc after reactivation of hepatitis B virus infection in an anti-HBs and anti-HBc-positive patient after allogeneic stem cell transplantation.
Gärtner BC; Jung W; Welsch C; Fischinger J; Schubert J; Zeuzem S; Mueller-Lantzsch N; Wend UC; Gerlich WH
J Clin Virol; 2007 Feb; 38(2):146-8. PubMed ID: 17182277
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus and HIV coinfection: relationship of different serological patterns to survival and liver disease.
Osborn MK; Guest JL; Rimland D
HIV Med; 2007 Jul; 8(5):271-9. PubMed ID: 17561872
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study.
Yeo W; Chan PK; Hui P; Ho WM; Lam KC; Kwan WH; Zhong S; Johnson PJ
J Med Virol; 2003 Aug; 70(4):553-61. PubMed ID: 12794717
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study.
Seto WK; Chan TS; Hwang YY; Wong DK; Fung J; Liu KS; Gill H; Lam YF; Lau EHY; Cheung KS; Lie AKW; Lai CL; Kwong YL; Yuen MF
Hepatology; 2017 May; 65(5):1451-1461. PubMed ID: 28027590
[TBL] [Abstract][Full Text] [Related]
31. HBV reactivation after kidney transplantation.
Berger A; Preiser W; Kachel HG; Stürmer M; Doerr HW
J Clin Virol; 2005 Feb; 32(2):162-5. PubMed ID: 15653420
[TBL] [Abstract][Full Text] [Related]
32. Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study.
Liu JH; Liao XW; Chen CH; Yao M; Li CC; Lin CT; Tsai CH; Chou WC; Hou HA; Huang SY; Wu SJ; Chen YC; Tien HF; Tang JL; Ko BS
Br J Haematol; 2019 Jul; 186(1):72-85. PubMed ID: 30919947
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention.
Mindikoglu AL; Regev A; Schiff ER
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1076-81. PubMed ID: 16861051
[TBL] [Abstract][Full Text] [Related]
36. [The effect of hepatitis B virus infection on the outcome of hematopoietic stem cell transplantation].
Du H; Wang M; Yang DL; Huang Y; Han MZ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Apr; 29(4):387-91. PubMed ID: 18844000
[TBL] [Abstract][Full Text] [Related]
37. Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HbsAb) disappearance post transplant, regardless of adoptive immunity transfer.
Kaloyannidis P; Batsis I; Yannaki E; Adamidou D; Bartzoudis D; Papathanasiou M; Mallouri D; Sakellari I; Fassas A; Anagnostopoulos A
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1049-56. PubMed ID: 17697967
[TBL] [Abstract][Full Text] [Related]
38. Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatment.
Nakamoto S; Kanda T; Nakaseko C; Sakaida E; Ohwada C; Takeuchi M; Takeda Y; Mimura N; Iseki T; Wu S; Arai M; Imazeki F; Saito K; Shirasawa H; Yokosuka O
Int J Mol Sci; 2014 Nov; 15(11):21455-67. PubMed ID: 25421241
[TBL] [Abstract][Full Text] [Related]
39. [Immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection].
Sato K
Gan To Kagaku Ryoho; 2011 Feb; 38(2):161-8. PubMed ID: 21368477
[TBL] [Abstract][Full Text] [Related]
40. Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation.
Idilman R; Arat M
Expert Rev Anti Infect Ther; 2011 Aug; 9(8):641-52. PubMed ID: 21819330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
